Cargando…
S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue
Background: S100A4 has recently emerged as an important player in cardiac disease, affecting phenotype development in animal models of myocardial infarction and pathological cardiac hypertrophy, albeit it is unclear whether S100A4 exerts a detrimental or beneficial function. The goal of the current...
Autores principales: | Braumann, Simon, Thottakara, Tilo, Stücker, Sabrina, Reischmann-Düsener, Silke, Krämer, Elisabeth, Groß, Julia, Hirt, Marc N., Doroudgar, Shirin, Carrier, Lucie, Friedrich, Felix W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157440/ https://www.ncbi.nlm.nih.gov/pubmed/30283351 http://dx.doi.org/10.3389/fphys.2018.01292 |
Ejemplares similares
-
Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
por: Stücker, Sabrina, et al.
Publicado: (2017) -
Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
por: Kresin, Nico, et al.
Publicado: (2019) -
A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy
por: Thottakara, Tilo, et al.
Publicado: (2021) -
Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
por: Schlossarek, Saskia, et al.
Publicado: (2014) -
Structure and dynamics of the ASB9 CUL-RING E3 Ligase
por: Lumpkin, Ryan J., et al.
Publicado: (2020)